source
- FDA clears Dexcom's Stelo as first OTC continuous glucose monitor for childrenThe U.S. Food and Drug Administration cleared Dexcom's Stelo Glucose Biosensor System for over-the-counter use in children two years of age and older who do not use insulin. This is the first OTC…
- Enliven Therapeutics raises $400M as Jazz's Zepzelca misses confirmatory trialEnliven Therapeutics, a biotech based in Burlingame, California, announced that it priced a public offering of its common stock that raised about $400 million. The capital raise follows the compan…